NasdaqCM - Delayed Quote USD
RenovoRx, Inc. (RNXT)
1.3000
-0.0600
(-4.41%)
At close: June 13 at 4:00:00 PM EDT
1.2917
-0.01
(-0.64%)
After hours: June 13 at 4:04:47 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.08 | -0.08 | -0.31 | -0.26 |
| Low Estimate | -0.08 | -0.08 | -0.32 | -0.29 |
| High Estimate | -0.08 | -0.08 | -0.31 | -0.24 |
| Year Ago EPS | -0.1 | -0.1 | -0.4 | -0.31 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 247.25k | 378k | 1.35M | 4.07M |
| Low Estimate | -- | -- | 197k | -- |
| High Estimate | 461k | 650k | 2M | 6M |
| Year Ago Sales | -- | -- | 43k | 1.35M |
| Sales Growth (year/est) | 0.00% | 0.00% | 3,041.86% | 201.41% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.11 | -0.12 | -0.12 | -0.08 |
| EPS Actual | -0.1 | -0.1 | -0.12 | -0.08 |
| Difference | 0.01 | 0.02 | 0.01 | -0.01 |
| Surprise % | 9.09% | 16.67% | 4.00% | -6.67% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.08 | -0.08 | -0.31 | -0.26 |
| 7 Days Ago | -0.08 | -0.08 | -0.32 | -0.26 |
| 30 Days Ago | -0.08 | -0.08 | -0.29 | -0.25 |
| 60 Days Ago | -0.07 | -0.07 | -0.29 | -0.27 |
| 90 Days Ago | -0.12 | -0.12 | -0.46 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | -- | 1 |
| Down Last 30 Days | 1 | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RNXT | 20.00% | 20.00% | 21.25% | 15.87% |
| S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Upgrades & Downgrades
| Maintains | Ascendiant Capital: Buy to Buy | 6/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/19/2025 |
| Maintains | Ascendiant Capital: Buy to Buy | 4/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/4/2025 |
| Initiated | HC Wainwright & Co.: Buy | 3/27/2025 |
| Maintains | Ascendiant Capital: Buy to Buy | 12/10/2024 |
Related Tickers
ABVC ABVC BioPharma, Inc.
1.7700
-4.32%
ENSC Ensysce Biosciences, Inc.
2.0700
-3.27%
VRPX Virpax Pharmaceuticals, Inc.
0.2320
-2.93%
ACTU Actuate Therapeutics, Inc. Common stock
8.65
+0.46%
TYRA Tyra Biosciences, Inc.
10.43
+0.97%
SPRC SciSparc Ltd.
0.3210
-1.05%
RNTX Rein Therapeutics Inc.
1.8800
-2.59%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.2100
-3.07%
FENC Fennec Pharmaceuticals Inc.
7.93
-4.69%
DRMA Dermata Therapeutics, Inc.
0.7123
-2.96%